Illness	Number of cases
Multiple myeloma and malignant plasma cell neoplasms - Multiple myeloma not having achieved remission (C90.00)	118
Malignant neoplasm of breast (C50.9)	66
Malignant neoplasm of breast (C50.8)	50
Malignant neoplasm of prostate (C61)	47
Malignant neoplasm of breast (C50.4)	43
Malignant neoplasm of pancreas - Malignant neoplasm of head of pancreas (C25.0)	38
Non-follicular lymphoma (C83.3)	36
Malignant neoplasm of ovary (C56)	35
Spread metastasis of cancer in otherwise unspecified areas of the body (C79.5)	26
Malignant neoplasm of oesophagus - Malignant neoplasm of lower third of esophagus (C15.5)	22

Top 10 treatments

Treatment	Number
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	1.011
Irradiation of the blood with UV light for the treatment of certain cancers - photopheresis (8-824)	509
Others therapeutic procedures to influence the immune system (8-547.0)	427
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12)	342
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.13)	212
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.14)	156
(9-984.7)	145
(9-984.8)	136
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	119
Other treatment by the targeted insertion of a needle with subsequent administration or removal of substances, e.g. fluid (8-159.x)	83

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0105

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ02
CQ05
CQ28
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
297	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
202	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
196	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities	Das Klinikum Bremen-Mitte ist mit mehr als 20 Dozenturen und/oder Lehrbeauftragungen an Universitäten im In- und Ausland durch seine Klinikdirektoren und leitenden Oberärzte vertreten.
Student training (clinical traineeship / internship year)	Am Klinikum Bremen-Mitte bieten mehr als 20 Kliniken die Möglichkeit eines praktischen Jahres/Famulatur an.
Project-related cooperation with colleges and universities	Prof. Bektas Prof. Dr. Cedidi, Prof. Dr. Dembinski, Prof. Dr. Kastrup, Dr. Körner, Prof. Dr. Lauten, Prof. Dr. Melchior, Prof. Dr. Naumann, Prof. Dr. Ockenga, Prof. Pekrun, Prof. Reinges, Prof. Dr. Dr. Rustemeyer, Prof. Dr. Winterhalter
Participation in multi-centre Phase I/II studies	Dr. Aydogdu, Prof. Dr. Hertenstein, Prof. Dr. Lemke PD Dr. Oberhoff Prof. Dr. Pekrun
Participation in multi-centre phase III/IV studies	Dr. Aydogdu, Prof. Dr. Dembinski, Prof. Dr. Hertenstein, Prof. Dr. Kastrup, Dr. Körner, Prof. Dr. Lemke, Prof. Dr. Melchior, Prof. Dr. Naumann, PD Dr. Oberhoff, Prof. Dr. Ockenga, Prof. Dr. Pekrun
Initiation and management of uni-centric/multi-centric clinical/scientific studies	Prof. Dr. Cedidi, Prof. Dr. Hertenstein, Prof. Dr. Kastrup, Prof. Dr. Lauten, Prof. Dr. Naumann, Prof. Dr. Dr. Rustemeyer, Prof. Dr. Winterhalter, Prof. Dr. Dembinski Prof. Dr. Ockenga Teilnahme am Projekt INTEGRATION, Innovationsfond, GBA
Editors of scientific journals/textbooks	Dr. Cebi, Prof. Dr. Dembinski, Prof. Dr. Naumann, Prof. Dr. Ockenga Prof. Dr. Dr. Rustemeyer Prof. Dr. Winterhalter
Doctoral supervision	Bektas/Cedidi/Dembinski/Hertenstein/Kastrup/Lauten/Lemke/Melchior/Ockenga/Oberhoff/Reinges/Rustemeyer/Winterhalter

Training

No.	Training in other healing professions	Comment
HB19	Nursing professionals	450 Plätze, Vertiefung akutstationäre Versorgung Erwachsene, Psychiatrie und Pädiatrie möglich
HB20	Nursing professional B. Sc.	Praktische Ausbildung in Kooperation mit der Hochschule Bremen
HB21	Geriatric nurse (m/f)	Praktische Ausbildung im Rahmen des PflBG
HB03	Physical therapist / physiotherapist (m/f)	78 Plätze
HB05	Medical technical radiology assistant (MTRA) (m/f)	neue Berufsbezeichnung: Medizinische Technologin bzw. medizinischer Technologe für Radiologie 60 Plätze Zusätzlich werden medizinische Fachangestellte/r (MFA) praktisch ausgebildet
HB06	Occupational therapist (m/f)	60 Plätze
HB07	Surgical technical assistant (m/f)	60 Plätze
HB09	Speech therapist (m/f)	60 Plätze
HB10	Midwife (m/f)	praktische Ausbildung
HB12	Medical technical laboratory assistant (MTLA) (m/f)	neue Berufsbezeichnung: Medizinische Technologin bzw. medizinischer Technologe für Laboratoriumsanalytik: 60 Plätze
HB15	Anaesthesia technical assistant (m/f)	60 Plätze
HB17	Auxiliary nurse (m/f)	40 Plätze
HB18	Emergency paramedics (m/f) (training period 3 years)	teilpraktische Ausbildung